(NASDAQ: IRIX) Iridex's forecast annual revenue growth rate of -0.13% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.58%.
Iridex's revenue in 2024 is $51,869,000.On average, 1 Wall Street analysts forecast IRIX's revenue for 2024 to be $841,895,713, with the lowest IRIX revenue forecast at $841,895,713, and the highest IRIX revenue forecast at $841,895,713.
In 2025, IRIX is forecast to generate $876,026,621 in revenue, with the lowest revenue forecast at $876,026,621 and the highest revenue forecast at $876,026,621.